Back to Journals » ClinicoEconomics and Outcomes Research » Volume 11
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,052 | Dovepress* | 11,422+ | 1,530 | 12,952 | |
PubMed Central* | 630 | 183 | 813 | ||
Totals | 12,052 | 1,713 | 13,765 | ||
*Since 21 March 2019 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
8 | 0 | 0 | 0 | 4 | 4 |
View citations on PubMed and Google Scholar